advanced search
Audrey Furness
Marketing Executive
ONdrugDelivery

Is this your profile?

About

Audrey Furness is Marketing Executive for ONdrugDelivery Magazine.

Contributions

PFIZER OUTLINES FIVE-POINT PLAN TO BATTLE COVID-19
Pfizer has called on the biopharmaceutical industry to join it in committing to unprecedented collaboration to combat COVID-19, issuing a five-point plan, which includes applying its drug development expertise, especially to help smaller companies, and offering its manufacturing capabilities.

More contributions

Nemera highlights obligation to provide life-saving devices to most vulnerable – including the elderly, asthmatics, diabetics
PRESS RELEASE In its COVID-19 press update, Nemera has highlighted its obligation to provide life-saving […]
The world in a state of emergency: How Sensirion helps save lives worldwide
Sensirion is lending its support to manufacturers of respiratory devices around the world to ensure their equipment is fitted with exceptionally accurate sensor technology allowing for time-resolved flow and volume measurements.
Stevanato guarantees primary packaging supplies for pharma glass containers and integrated medical device solutions
In its COVID-19 announcement, Stevanato Group has confirmed that as a major manufacturer of glass containers for pharma and a supplier of integrated solutions for medical devices is guaranteeing primary packaging supplies to support patient care worldwide.
AS DEMAND SURGES, NEPHRON PREPARED TO MEET AMERICA’S NEEDS FOR RESPIRATORY MEDS
Nephron Pharmaceuticals has released a statement detailing how current demand for its medications - inhalation solutions and suspension products that treat respiratory conditions - is surging and the company is shattering sales records.
Synairgen to start trial of SNG001 in COVID-19 imminently
Synairgen has announced that it has received expedited approvals from the UK Medicines and Healthcare products Regulatory Agency (MHRA) and Health Research Authority (HRA) to conduct a trial of SNG001 (inhaled formulation of interferon-beta-1a) in COVID-19 patients to assist with the global outbreak of the virus.
US FDA Issues Guidance for Conducting Clinical Trials during the COVID-19 pandemic.
“With this guidance issued today, the FDA is helping industry and investigators navigate the COVID-19 […]
MannKind Refocuses Pipeline Resources in Response to COVID-19 Pandemic
MannKind Corporation is adjusting R&D resources that were reserved for its pipeline of investigational products for treating serious lung diseases, with the goal of prioritising work on new compounds that may have the potential to address the morbidity and mortality associated with respiratory viral infections, such as COVID-19.
PBOA Members Committed To Continuing To Reliably Manufacture Drug and Vaccine Products
PBOA reports how its member companies remain committed to serving patients by manufacturing effective, quality products for their customers, during this global health crisis, and report no material disruptions to their operations.
Insmed Provides Covid-19 Business Update
Insmed implements corporate initiatives in response to the novel coronavirus (SARS-CoV-2) global pandemic including a remote working policy to allow infectious disease specialists and pulmonologists to focus on treating patients and containing the virus. Arikares trainers will now offer remote training and onboarding for patients who initiate treatment with ARIKAYCE.
Beyond Air Submits Investigational Device Exemption to FDA for the Treatment of COVID-19
Beyond Air has submitted an IDE to the US FDA for use of its LungFit™ BRO system in the treatment of COVID-19 patients stating that a mounting body of evidence that NO is safe and well tolerated and in vitro evidence points to inhibition of viral replication in coronaviruses.
CONNECTIVITY
PRODUCT SHOWCASE: Injay – Connected Prefilled Syringe
Biocorp presents Injay, the first prefilled syringe with built-in connectivity, providing a cost-effective and easy-to-implement solution that improves treatment adherence, upholds quality of reporting, and provides a secure treatment protocol and traceability.
EXPERT VIEW
COMPACTION SIMULATION / INDUSTRIAL PRESS CORRELATION: TWO CASE STUDIES
Aline Moulin and Lucile Kowalski examine two case studies comparing compaction simulation with industrial compression.
NASAL
NASAL DRUG DELIVERY VIA THE ORAL ROUTE USING A PMDI
Laurent Vecellio, Déborah Le Pennec and Alain Regard, Technology Product Manage discuss a study Nemera has funded into the retronose concept, using a pMDI to deliver to the nasal cavity via the oral route during exhalation through the nose.
Top